Abstract:Objective To investigate the effect of Qilin Pills (QP) in facilitating the recovery of spermatogenic function in azoospermia (AS) mice and to explore its mechanism of regulating testicular spermatogenesis. METHODS Fifteen 4-week-old male mice were equally randomized into an AS model control, a low-dose QP and a high-dose QP group. The AS model was established in the mice by intraperitoneal injection of busulfan at 35 mg/kg. After modeling, the animals in the low- and high-dose QP groups were treated with Qilin Pills intragastrically at 2 000 and 8 000 mg/kg/d respectively while those in the model control group fed on a normal diet, all for 28 days. Then, all the mice were sacrificed for examination of the ultrastructures of the epididymis and testis by HE staining, detection of the specific markers of spermatogenic, Sertoli and Leydig cells by Western blot, and determination of the expressions of these markers in the testis tissue by immunofluorescence assay. RESULTS The number of spermatogenic cells in the testis tissue was significantly decreased in the AS model controls, with no spermatozoa in most of the seminiferous tubules in the epididymis (Johnsen's score: 5.2 ± 0.5). In the high-dose QP group, spermatogenic cells were tightly arranged with distinct layers in the seminiferous tubules, with a large number of spermatozoa but no non-sperm cells in the lumens of the epididymis (Johnsen's score: 9.4 ± 0.6). The number of spermatogenic cells in the testis was increased in the low-dose QP group with some spermatozoa in the seminiferous tubules as compared with that in the model control, but lower than in the high-dose group (Johnsen's score: 7.6 ± 0.6). The Johnsen's score was significantly lower in the model control than in the high- and low-dose QP groups (P < 0.01), and higher in the high-dose than in the low-dose QP group (P < 0.05). The expressions of the specific markers of Sertoli cells SCF, BMP4, SYCP3, DMC1 and Ki67 were also remarkably lower in the model control than in the high- and low-dose QP groups (P < 0.01), and higher in the high-dose than in the low-dose QP group (P < 0.05 or P < 0.01). No statistically significant differences were observed among the three groups of mice in the markers of spermatogonial stem cells (SSC) and undifferentiated SSCs UCHL1, STRA8, NGN3 and PLZF3 (P > 0.05). The expressions of the spermatocyte markers DMC1 and SYCP3 were markedly lower in the model control than in the high- and low-dose QP groups (P < 0.05 or P < 0.01), and higher in the high-dose than in the low-dose QP group (P < 0.05 or P < 0.01). The Ki67 fluorescence signals were distributed in the spermatogonia, with a higher intensity in the model control than in the high- and low-dose QP groups. The acrosome marker PNA was found mainly in the seminiferous tubules, with abundant fluorescence signals in the high- and low-dose QP groups but no obvious dot signals in the model controls. CONCLUSIONS Qilin Pills may contribute to the meiosis of spermatogonia and promote spermatogenesis by improving the function of Sertoli cells in the testis.

Clinical efifcacy of Qilinpill in the treatment of oligoasthernospermia

[Qilin Pills for Oligoasthenospermia: a Multi-Centered Clinical Trial].

Clinical Research on Treatment of Oligospermia and Asthenospermia with Guiqishengjing Capsule

Improvement of Qilin pills on male reproductive function in tripterygium glycoside-induced oligoasthenospermia in rats

Clinical trial of shengjing capsule's efficacy on oligoasthernospermia

Clinical observation on the effects of Zuogui pill on patients with oligoasthenospermia of kidney yin deficiency type

Clinical observation of Compound Xuanju Capsule combined with Testosterone Undecanoate Capsule in treatment of oligoasthenospermia

Study of Jinkui Shenqi Pill combined Kallidinogenase on Treating Asthenospermia

Effects of Qilin pills on spermatogenesis, reproductive hormones, oxidative stress, and the TSSK2 gene in a rat model of oligoasthenospermia

Clinical Efficacy of Yixinkangtai Capsule in Patients with Oligospermia and Asthenospermia

Multi-centered clinical trial of Longlu Capsule for oligoasthenospermia

Clinical research of Compound Xuanju Capsule treating oligoathenospermia due to spleen and kidney Yang deficiency

[Qilin Pills Combined with Levofloxacin for Asthenospermia Accompanied with Accessory Sex Gland Infection: a Clinical Observation].

[Multi-Centered Clinical Trial of Fufang Xuanju Capsule for Oligoasthenospermia].

Treatment of 1276 cases of oligo/asthenozoospermia using yishenshengjing granules

[On Oligozoospermia and Asthenospermia].

The combination of Clomifene with Pentoxifylline in treating idiopathic oligoasthenozoospermia patients

[Qilin Pills Promote Testicular Spermatogenesis in Azoospermia Mice].

Effectiveness comparison of a Chinese dicitraditionalmene formula Wuzi Yanzong Pill and its analogous prescriptions for the treatment of oligoasthenozoospermia: A systematic review and meta-analysis protocol

Multi-center clinical trial of LiShenBao (uFSH) in the treatment of severe oligoasthenospermia

Clinical observation of Qilin pills combined with Weishenxin capsules for the sperm DNA damage of infertile male patients with recurrent spontaneous abortion